KIT and neoplasm: Moreover, the anti-tumor efficacy and biosafety of KIT-d-MMAE were observed in several tumor models (cell line-derived xenograft, patient-derived xenograft, liver metastasis tumor model, and spontaneous tumor model) (Scheme 1B).